Bacterin Completes $3M Private Placement to Develop Biological Scaffolds for Orthopedic Indications

Bacterin International, Inc. (Bacterin), a developer of biological scaffolds for orthopedic indications, today announced the completion of a $3 million private placement of Secured Convertible Promissory Notes led by Middlebury Securities, LLC

Proceeds from the raise will be used to repay approximately $800,000 of existing debt and the remainder will be used to expand the Company’s sales and marketing effort and general working capital purposes.

The Company’s products, OsteoSponge, OsteoSpongeSC and OsteoWrap, are made from demineralized bone that is malleable and flexible, which enables more efficient and precise handling. It also markets OsteoLock, used in spine surgery, minimizes graft back-out, and increases osteoinductivity.

Yahoo Finance…  http://ow.ly/177CR

Uncategorized